Jälki-ilmoitus EU-hankinta

Potassium iodide 130 mg and 65 mg / 2023-2024

Finnish Institue for Health and Welfare · koko Suomi

Perustiedot

Hankkija
Finnish Institue for Health and Welfare, Y-tunnus 2229500-6
Toteutuspaikka
koko Suomi
Hankintalaji
Tavarahankinta
Menettely
Avoin menettely, EU-hankinta
Ilmoituksen tyyppi
Jälki-ilmoitus
Sopimusten kokonaisarvo
1 € (alv 0 %)
Erät
2 erää
Pääasiallinen CPV
33695000 Kaikki muut ei-terapeuttiset valmisteet
Lisäkoodit: 33600000
Sopimuskausi
11 kuukautta
Julkaistu
15.3.2024

Hankinnan tulos

Erä Voittaja Sopimusarvo Tarjouksia Päätös
Erä 1: LOT 1: Potassium iodide 130 mg G.L. Pharma Nordic AB ei ilmoitettu ei ilmoitettu
Erä 2: LOT 2: Potassium iodide 65 mg G.L. Pharma Nordic AB ei ilmoitettu ei ilmoitettu

Voittajista näytetään nimi ja Y-tunnus. ”Ei ilmoitettu” tarkoittaa, ettei ilmoituksessa ole tätä tietoa erälle tai sopimukselle.

Ilmoituksen teksti

Alkuperäinen teksti Hilmasta, muuttamattomana
The scope of the procurement is Potassium iodide 130 mg and 65 mg to the rescEU project. The Scope of procurement is described in more detail in the Call for tenders and its Annexes. The procurement is divided in two (2) lots. Tender may be submitted for one or several lots. LOT 1: Potassium iodide 130 mg LOT 2: Potassium iodide 65 mg The contract will be awarded to one Supplier for each lot based on a comparison of tenders. Tender that is economically the most advantageous will win the competition. The contract period shall enter into force once the contract has been signed by contracting parties and expires when all contractual duties of the contract have been performed. Call for Tenders, Annexes: Annex 1 Scope of the procurement Annex 1.1 Minimum requirements for lot 1 Annex 1.2 Minimum requirements for lot 2 Annex 2 Contract Annex 3 Description of the Handi service Annex 4 JYSE 2014 SUPPLIES (updated version of April 2022) Annex 5 Estimated quantity (restricted, TLIV) Annex 6 Confidentiality commitment

Lisätiedot

The availability for the Annex 5 is restricted. THL will send the restricted Annex 5 to a representative of the tenderer via encrypted email after THL has received the signed confidentiality commitment (Annex 6) during the tendering process. Confidentiality commitment shall be signed in person for each person handling Annex 5. Confidentiality commitment shall be sent to the email address kirjaamo@thl.fi with the subject line "CONFIDENTIALITY COMMITMENT - THL/4526/2.02.06/2023 / Potassium iodide 130 mg and 65 mg / 2023-2024". The message must contain name of the tenderer and email address to which the restricted Annex 5 is to be sent.

Erien kuvaukset

Erä 1: LOT 1: Potassium iodide 130 mg
The subject of the procurement is article in accordance with the following requirements: - The subject of tender: “Potassium iodide 130 mg” - Active pharmaceutical ingredient: Potassium iodide - Pharmaceutical form: tablets - Package size: 10 - 100 tablets in blisters or in bottles. The minimum requirements of the article is described in more detail in Annex 1.1 to the Call for tenders. The article can be offered in a strength of 130 mg tablet or, alternatively, twice that amount in a strength of 65 mg tablets. Estimated quantity for the article is described in Annex 5 (restricted, TLIV) to the Call for tenders. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.
Erä 2: LOT 2: Potassium iodide 65 mg
The subject of the procurement is article in accordance with the following requirements: - The subject of tender: “Potassium iodide 65 mg” - Active pharmaceutical ingredient: Potassium iodide - Pharmaceutical form: tablets - Package size: 10 - 100 tablets in blisters or in bottles. The minimum requirements of the article is described in more detail in Annex 1.2 to the Call for tenders. Estimated quantity for the article is described in Annex 5 (restricted, TLIV) to the Call for tenders. The contract will be awarded to one Supplier based on a comparison of tenders. Tender that is economically the most advantageous will win the competition.

Erät

Erä Nimi Ammattiala Arvioitu arvo CPV
1 LOT 1: Potassium iodide 130 mg – – 33695000, 33600000
2 LOT 2: Potassium iodide 65 mg – – 33695000, 33600000

Hankinnan vaiheet

  1. –Hankintailmoitus

    Aiempi versio. Sen tiedot eivät ole Urakkahaussa.

  2. Muutosilmoitus

    Ostajan virheen korjaaminen.

  3. Jälki-ilmoitustämä ilmoitus

    Voittaja: G.L. Pharma Nordic AB.

Lähde: Hilma (hankintailmoitukset.fi)

Ilmoitus 2024-006999

Ilmoita virheestä tai pyydä poistoa